Results 171 to 180 of about 25,105,841 (305)

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Understanding Implementation of the Family and Community Nurse Role Using Consolidated Framework for Implementation Research: A Case Study. [PDF]

Nurs Res Pract
Busca E, Bassi E, Milani S, Di Massimo DS, Miotto M, Tosatti S, Zampelli L, Jack SM, Dal Molin A.   +8 more
europepmc   +1 more source

Academic performance and learning style self-predictions by second language students in an introductory biology course

Journal of the Scholarship of Teaching and Learning, 2012
Jennifer Breckler, Chia Shan Teoh, Kemi Role   +2 more
doaj  

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

Molecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola, Rafael Lopes Goncalves, Marin Truchi, Caroline Lacoux, Célia Scribe, Hugo Cadis, Laetitia Guardini, Sophie Bekisz, Marius Ilié, Paul Hofman, Georges Vassaux, Bernard Mari, Roger Rezzonico   +12 more
wiley   +1 more source

Incidence and Survival Rates of Frontotemporal Lobar Degeneration: Population-Based Registry Study. [PDF]

Neurology
Nagel G, Peter RS, Uzelac Z, Wernecke D, Niehaus L, Trottenberg T, Jöbges M, Dettmers C, Bäzner H, Börtlein A, Althaus K, Mayer-Freitag K, Ratzka P, Naumann M, Lindner A, Chatzikonstantinou A, Andres F, Arnold G, Blickhan M, Opherk C, Knier B, Ertl M, Metrikat J, Huber R, Thomas C, Kozian R, Kimmig H, Demuth K, Hecht M, Foerch C, Kloetsch C, Reinhard M, Bengel D, Neuhaus O, Buttmann M, Volkmann J, Pinkhardt E, Lichy C, Laske C, Beattie J, Häckert J, Jesse S, Brenner D, Weishaupt J, Otto M, Uttner I, Anderl-Straub S, Lulé DE, Rothenbacher D, Rosenbohm A, Ludolph AC, ALS-FTLD Registry Swabia Study Group.   +51 more
europepmc   +1 more source

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

Molecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone, James Dunford, Eleanor Calcutt, Vicki Gamble, Filiz Senbabaoglu Aksu, Lorena Ligammari, Georgina Wherry, Giorgia Gaeta, John C. Christianson, Adrienne M. Flanagan, Udo Oppermann, Adam P. Cribbs   +11 more
wiley   +1 more source

Deux outils pour les bibliothèques distribuées [PDF]

Role, François
core  

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

Molecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken, Andrea Abel Gutierrez, Imke van Rossum, Cornelia G. Spruijt, Michiel Vermeulen, Guido van Mierlo, Blanca Scheijen, Annemiek B. van Spriel   +7 more
wiley   +1 more source

The prospects of targeting messenger RNA surveillance factor PELOTA for developing virus resistance in plants. [PDF]

Plant Mol Biol
Majumdar A, Babu YM, Mondal F, Sarkar M, Mazumder P, Pradhan P, Kumar R, Koeda S, Roy A.   +8 more
europepmc   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source